Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis B vaccine: current issues

R Zannolli1, G Morgese

  • 1University of Siena, Italy.

The Annals of Pharmacotherapy
|September 20, 1997
PubMed
Summary
This summary is machine-generated.

Hepatitis B vaccine nonresponders can often achieve immunity with modified vaccination strategies. Routine booster doses are debated, with US experts recommending delayed boosters and limited testing, while European experts advocate for regular antibody assessment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Problems in the management of obese adolescents: safety and effectiveness of unbalanced low caloric diet?

International journal of adolescent medicine and health·2012
Same author

Corpus callosum abnormalities, intellectual disability, speech impairment, and autism in patients with haploinsufficiency of ARID1B.

Clinical genetics·2011
Same author

Neurological outcome following isolated 10-12 mm fetal ventriculomegaly.

Archives of disease in childhood. Fetal and neonatal edition·2009
Same author

Efficacy and safety of levetiracetam in infants and young children with refractory epilepsy.

Seizure·2007
Same author

Aicardi syndrome with favorable outcome: case report and review.

Brain & development·2007
Same author

Intractable reflex audiogenic seizures in Aicardi syndrome.

Brain & development·2006
Same journal

Stability of Ceftazidime-Avibactam: Changes in Regulatory Information and Implications for Preparation.

The Annals of pharmacotherapy·2026
Same journal

Impact of Early Dose Adjustment of Piperacillin/Tazobactam on Mortality in Critically Ill Patients With Acute Kidney Injury: A Retrospective Multicenter Cohort Study.

The Annals of pharmacotherapy·2026
Same journal

Severe Phototoxic Skin Reaction Associated With Vandetanib: Implications for Pharmaceutical Care.

The Annals of pharmacotherapy·2026
Same journal

Efficacy and Safety of Oral PCSK9 Inhibitors in Adults With Hypercholesterolemia: An Updated Systematic Review and Meta-Analysis of RCTs.

The Annals of pharmacotherapy·2026
Same journal

RSVpreF: A Vaccine for the Respiratory Syncytial Virus.

The Annals of pharmacotherapy·2026
Same journal

Severe Acute Hepatitis Induced by Combined Rosuvastatin and Ticagrelor Therapy Post-PCI: The Challenges of Multi-Drug DILI Diagnosis.

The Annals of pharmacotherapy·2026
See all related articles

Area of Science:

  • Immunology
  • Vaccinology
  • Public Health

Background:

  • Hepatitis B vaccination is crucial for preventing infection.
  • Challenges exist in managing individuals who do not respond to the vaccine.
  • Debate surrounds the necessity and timing of booster doses for sustained immunity.

Purpose of the Study:

  • To review current strategies for managing nonresponders to the hepatitis B vaccine.
  • To analyze the differing expert opinions on the need for routine booster doses.
  • To provide clarity on vaccination protocols for hepatitis B.

Main Methods:

  • Literature review of studies published between 1980 and 1996.
  • Analysis of cited references from relevant articles.
  • Synthesis of findings on vaccine response and booster dose recommendations.

Related Experiment Videos

Main Results:

  • Nonresponders may achieve seroconversion with altered vaccination schedules (e.g., increased doses).
  • Cytokine adjuvants show limited benefit in nonresponders.
  • US experts suggest delayed boosters and targeted antibody testing for high-risk groups.
  • European experts propose routine antibody assessment and interval boosters, though timing remains controversial.

Conclusions:

  • Modified vaccination strategies can induce seroconversion in nonresponders.
  • Current evidence suggests limited utility for cytokine adjuvants.
  • US expert recommendations on booster doses offer a practical approach.
  • A consensus is needed to reconcile differing international guidelines on hepatitis B vaccine boosters.